TRPV1 Agonist Approaches for Pain Management
This chapter contains sections titled: Introduction TRPV1 Agonist ‐ Induced Nociceptor Defunctionalization Nociceptor Hyperactivity Bases for Nociceptor Hyperactivity TRPV1 Agonist ‐ Induced Disruption of Nociceptor Hyperactivity Potential Indications for Locally Administered TRPV1 Agonists Painful...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buchkapitel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 347 |
---|---|
container_issue | |
container_start_page | 325 |
container_title | |
container_volume | |
creator | Bley, Keith R |
description | This chapter contains sections titled:
Introduction
TRPV1 Agonist ‐ Induced Nociceptor Defunctionalization
Nociceptor Hyperactivity
Bases for Nociceptor Hyperactivity
TRPV1 Agonist ‐ Induced Disruption of Nociceptor Hyperactivity
Potential Indications for Locally Administered TRPV1 Agonists
Painful Peripheral Neuropathies
Traumatic and Musculoskeletal Pain
Migraine and Headache
Vulvodynia and Mucosal Disorders
Bladder Pain and Overactivity
Conclusions
References |
doi_str_mv | 10.1002/9780470588284.ch13 |
format | Book Chapter |
fullrecord | <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_ebooks_10_1002_9780470588284_ch13_ch13</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10.1002/9780470588284.ch13</sourcerecordid><originalsourceid>FETCH-LOGICAL-s153f-88f163507707a09996354ab8dc84f079c56b40d039de496088f16834fc5e99fe3</originalsourceid><addsrcrecordid>eNptj19LwzAUxSMiqHNfwKd-AFtvmqQ3eSzDfzDZkOlrSNNkq86mLAPRT2-3CjLYfbiXcznnwI-QawoZBchvFUrgCELKXPLMrig7IZf_n9NBUBQCxTkZx_gO_bACc6QX5GbxMn-jSbkMbRO3Sdl1m2DsysXEh00yN02bPJvWLN2na7dX5MybdXTjvzsir_d3i8ljOp09PE3KaRqpYD6V0tOCCUAENKCU6gU3layt5B5QWVFUHGpgqnZcFbD3S8a9FU4p79iIsKH3q1m7b-2qED6ipqB3wPoAWO-A96tPZUdSh-6fphsSXe3ZL1XxVhw</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>book_chapter</recordtype></control><display><type>book_chapter</type><title>TRPV1 Agonist Approaches for Pain Management</title><source>eBooks on EBSCOhost</source><creator>Bley, Keith R</creator><contributor>Gomtsyan, Arthur ; Faltynek, Connie R</contributor><creatorcontrib>Bley, Keith R ; Gomtsyan, Arthur ; Faltynek, Connie R</creatorcontrib><description>This chapter contains sections titled:
Introduction
TRPV1 Agonist ‐ Induced Nociceptor Defunctionalization
Nociceptor Hyperactivity
Bases for Nociceptor Hyperactivity
TRPV1 Agonist ‐ Induced Disruption of Nociceptor Hyperactivity
Potential Indications for Locally Administered TRPV1 Agonists
Painful Peripheral Neuropathies
Traumatic and Musculoskeletal Pain
Migraine and Headache
Vulvodynia and Mucosal Disorders
Bladder Pain and Overactivity
Conclusions
References</description><identifier>ISBN: 0470175575</identifier><identifier>ISBN: 9780470175576</identifier><identifier>EISBN: 0470588284</identifier><identifier>EISBN: 9780470588284</identifier><identifier>DOI: 10.1002/9780470588284.ch13</identifier><language>eng</language><publisher>Hoboken, NJ, USA: John Wiley & Sons, Inc</publisher><subject>TRPV1 agonist approaches for pain management ; TRPV1 agonist‐based therapies – viability unlikely, side‐effect profile of defunctionalization, unlikely to be acceptable ; TRPV1 agonist‐induced disruption of nociceptor hyperactivity</subject><ispartof>Vanilloid Receptor TRPV1 in Drug Discovery, 2010, p.325-347</ispartof><rights>Copyright © 2010 John Wiley & Sons, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>775,776,780,789,27902</link.rule.ids></links><search><contributor>Gomtsyan, Arthur</contributor><contributor>Faltynek, Connie R</contributor><creatorcontrib>Bley, Keith R</creatorcontrib><title>TRPV1 Agonist Approaches for Pain Management</title><title>Vanilloid Receptor TRPV1 in Drug Discovery</title><description>This chapter contains sections titled:
Introduction
TRPV1 Agonist ‐ Induced Nociceptor Defunctionalization
Nociceptor Hyperactivity
Bases for Nociceptor Hyperactivity
TRPV1 Agonist ‐ Induced Disruption of Nociceptor Hyperactivity
Potential Indications for Locally Administered TRPV1 Agonists
Painful Peripheral Neuropathies
Traumatic and Musculoskeletal Pain
Migraine and Headache
Vulvodynia and Mucosal Disorders
Bladder Pain and Overactivity
Conclusions
References</description><subject>TRPV1 agonist approaches for pain management</subject><subject>TRPV1 agonist‐based therapies – viability unlikely, side‐effect profile of defunctionalization, unlikely to be acceptable</subject><subject>TRPV1 agonist‐induced disruption of nociceptor hyperactivity</subject><isbn>0470175575</isbn><isbn>9780470175576</isbn><isbn>0470588284</isbn><isbn>9780470588284</isbn><fulltext>true</fulltext><rsrctype>book_chapter</rsrctype><creationdate>2010</creationdate><recordtype>book_chapter</recordtype><sourceid/><recordid>eNptj19LwzAUxSMiqHNfwKd-AFtvmqQ3eSzDfzDZkOlrSNNkq86mLAPRT2-3CjLYfbiXcznnwI-QawoZBchvFUrgCELKXPLMrig7IZf_n9NBUBQCxTkZx_gO_bACc6QX5GbxMn-jSbkMbRO3Sdl1m2DsysXEh00yN02bPJvWLN2na7dX5MybdXTjvzsir_d3i8ljOp09PE3KaRqpYD6V0tOCCUAENKCU6gU3layt5B5QWVFUHGpgqnZcFbD3S8a9FU4p79iIsKH3q1m7b-2qED6ipqB3wPoAWO-A96tPZUdSh-6fphsSXe3ZL1XxVhw</recordid><startdate>20100212</startdate><enddate>20100212</enddate><creator>Bley, Keith R</creator><general>John Wiley & Sons, Inc</general><scope/></search><sort><creationdate>20100212</creationdate><title>TRPV1 Agonist Approaches for Pain Management</title><author>Bley, Keith R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s153f-88f163507707a09996354ab8dc84f079c56b40d039de496088f16834fc5e99fe3</frbrgroupid><rsrctype>book_chapters</rsrctype><prefilter>book_chapters</prefilter><language>eng</language><creationdate>2010</creationdate><topic>TRPV1 agonist approaches for pain management</topic><topic>TRPV1 agonist‐based therapies – viability unlikely, side‐effect profile of defunctionalization, unlikely to be acceptable</topic><topic>TRPV1 agonist‐induced disruption of nociceptor hyperactivity</topic><toplevel>online_resources</toplevel><creatorcontrib>Bley, Keith R</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bley, Keith R</au><au>Gomtsyan, Arthur</au><au>Faltynek, Connie R</au><format>book</format><genre>bookitem</genre><ristype>CHAP</ristype><atitle>TRPV1 Agonist Approaches for Pain Management</atitle><btitle>Vanilloid Receptor TRPV1 in Drug Discovery</btitle><date>2010-02-12</date><risdate>2010</risdate><spage>325</spage><epage>347</epage><pages>325-347</pages><isbn>0470175575</isbn><isbn>9780470175576</isbn><eisbn>0470588284</eisbn><eisbn>9780470588284</eisbn><abstract>This chapter contains sections titled:
Introduction
TRPV1 Agonist ‐ Induced Nociceptor Defunctionalization
Nociceptor Hyperactivity
Bases for Nociceptor Hyperactivity
TRPV1 Agonist ‐ Induced Disruption of Nociceptor Hyperactivity
Potential Indications for Locally Administered TRPV1 Agonists
Painful Peripheral Neuropathies
Traumatic and Musculoskeletal Pain
Migraine and Headache
Vulvodynia and Mucosal Disorders
Bladder Pain and Overactivity
Conclusions
References</abstract><cop>Hoboken, NJ, USA</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/9780470588284.ch13</doi><tpages>23</tpages></addata></record> |
fulltext | fulltext |
identifier | ISBN: 0470175575 |
ispartof | Vanilloid Receptor TRPV1 in Drug Discovery, 2010, p.325-347 |
issn | |
language | eng |
recordid | cdi_wiley_ebooks_10_1002_9780470588284_ch13_ch13 |
source | eBooks on EBSCOhost |
subjects | TRPV1 agonist approaches for pain management TRPV1 agonist‐based therapies – viability unlikely, side‐effect profile of defunctionalization, unlikely to be acceptable TRPV1 agonist‐induced disruption of nociceptor hyperactivity |
title | TRPV1 Agonist Approaches for Pain Management |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=bookitem&rft.atitle=TRPV1%20Agonist%20Approaches%20for%20Pain%20Management&rft.btitle=Vanilloid%20Receptor%20TRPV1%20in%20Drug%20Discovery&rft.au=Bley,%20Keith%20R&rft.date=2010-02-12&rft.spage=325&rft.epage=347&rft.pages=325-347&rft.isbn=0470175575&rft.isbn_list=9780470175576&rft_id=info:doi/10.1002/9780470588284.ch13&rft_dat=%3Cwiley%3E10.1002/9780470588284.ch13%3C/wiley%3E%3Curl%3E%3C/url%3E&rft.eisbn=0470588284&rft.eisbn_list=9780470588284&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |